Back
Jones Lang LaSalle, Inc. Vs. Alnylam Pharmaceuticals, Inc. Industry Stock Comparison
Buy
76
JLL
Jones Lang LaSalle, Inc.
Last Price:
$346.74
Seasonality Move:
9.44%
Sell
45
ALNY
Alnylam Pharmaceuticals, Inc.
Last Price:
$400.79
Seasonality Move:
0.84%
Buy
76
Jones Lang LaSalle, Inc. (JLL)
is a Buy
Is Jones Lang LaSalle, Inc. a Buy, Sell or Hold?
-
The current Jones Lang LaSalle, Inc. [JLL] share price is $346.91. The Score for JLL is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
-
JLL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Alnylam Pharmaceuticals, Inc. (ALNY)
is a Sell
Is Alnylam Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals, Inc. [ALNY] share price is $400.69. The Score for ALNY is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
JLL Stock Price Chart
What is Jones Lang LaSalle, Inc.'s stock price today?
-
The Jones Lang LaSalle, Inc. share price today is $346.91Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JLL is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals, Inc.'s stock price today?
-
The Alnylam Pharmaceuticals, Inc. share price today is $400.69Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
JLL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.86 | Buy |
| Relative Strength Index (14 RSI): | 69.46 | Buy |
| Chaikin Money Flow: | 89873 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (317.67 - 338.57) | Buy |
| Bollinger Bands (100): | (291.2 - 323.58) | Buy |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -13.98 | Sell |
| Relative Strength Index (14 RSI): | 38.99 | Sell |
| Chaikin Money Flow: | 309036 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (399.2 - 453.4) | Sell |
| Bollinger Bands (100): | (425.75 - 469.75) | Sell |
JLL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 337.07 | Buy |
| 20-day SMA: | 331.7 | Buy |
| 50-day SMA: | 315.86 | Buy |
| 200-day SMA: | 273.55 | Buy |
| 8-day EMA: | 338.62 | Buy |
| 20-day EMA: | 331.07 | Buy |
| 50-day EMA: | 318.95 | Buy |
| 200-day EMA: | 286.37 | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 397.27 | Buy |
| 20-day SMA: | 422.53 | Sell |
| 50-day SMA: | 442.75 | Sell |
| 200-day SMA: | 368.05 | Buy |
| 8-day EMA: | 402.46 | Sell |
| 20-day EMA: | 415.69 | Sell |
| 50-day EMA: | 431.03 | Sell |
| 200-day EMA: | 383.3 | Buy |
Jones Lang LaSalle, Inc. Earnings Growth & JLL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.96 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.68 per share, and an increase next year of $2.98 per share.
Alnylam Pharmaceuticals, Inc. Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.20 per share, and an increase next year of $6.23 per share.
Jones Lang LaSalle, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||